PR NewswireSynthetic Biology Market to Reach 21.1 Billion USD by 2023 – IndustryARCMarketWatchThe Report "Synthetic Biology Market: By Tool (XNAS, Chassis Organisms, Oligonucleotides, Cloning Technology Kits); By Technology (Bioinformatics, DNA Se… Continue reading
PR NewswireSynthetic Biology Market to Reach 21.1 Billion USD by 2023 – IndustryARCMarketWatchThe Report "Synthetic Biology Market: By Tool (XNAS, Chassis Organisms, Oligonucleotides, Cloning Technology Kits); By Technology (Bioinformatics, DNA Se… Continue reading
St. Louis Public RadioIn a race to prevent hunger, Danforth researchers use CRISPR to gene-edit cassavaSt. Louis Public RadioThe plan is to use CRISPR — a cheaper, faster way to genetically modify crops — to grow cassava plants that are resistant to co… Continue reading
|
Canadian Patent Office to Grant Merck’s Patent Application for CRISPR Technology
PR Newswire India (press release) DARMSTADT, Germany, Oct. 24, 2017 /PRNewswire/ — Merck, a leading science and technology company, today announced that the Canadian Patent Office has issued a “Notice of Allowance” for Merck’s patent application covering the company’s CRISPR … |
|
AbbVie bets on Alzheimer’s immunotherapy with big biotech deal
Reuters The idea of using immunotherapy in Alzheimer’s mirrors the success of immuno-oncology in cancer, where drugs that help the immune system battle tumors are revolutionizing care. Scientists at AbbVie and Alector believe there is growing evidence that … |
|
Canadian Patent Office to Grant Merck’s Patent Application for CRISPR Technology
PR Newswire UK (press release) DARMSTADT, Germany, Oct. 24, 2017 /PRNewswire/ — Merck, a leading science and technology company, today announced that the Canadian Patent Office has issued a “Notice of Allowance” for Merck’s patent application covering the company’s CRISPR … |
|
Canadian Patent Office to Grant MilliporeSigma’s Patent Application for CRISPR Technology
Canada NewsWire (press release) “Our patent portfolio continues to grow worldwide, extending protection for our unique CRISPR technology as we work with the global scientific community to find new treatments for diseases,” said Udit Batra, CEO, MilliporeSigma. “This decision by the … |
TheChronicleHerald.ca |
Dalhousie gene research team seeks international competition gold
TheChronicleHerald.ca What do a porcupine and biofuel have in common? This isn’t a trick question but one that the amazing minds at Dalhousie iGEM have been working on all summer in an effort to bring their best synthetic biology foot forward at this year’s iGEM competition. |